Cellular Immunotherapy (Arbele/Avalon GloboCare) Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Cellular Immunotherapy (Arbele/Avalon GloboCare) General Information

Description

Provider of transposon-based Chimeric Antigen Receptor (CAR)-T and CAR-Natural Killer (NK) cellular therapies intended to treat advanced stages of cancers. The company's focus is to accelerate the clinical programs in cellular therapy and lead the research in the field of cellular immunotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellular Immunotherapy (Arbele/Avalon GloboCare) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cellular Immunotherapy (Arbele/Avalon GloboCare)‘s full profile, request access.

Request a free trial

Cellular Immunotherapy (Arbele/Avalon GloboCare) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cellular Immunotherapy (Arbele/Avalon GloboCare)‘s full profile, request access.

Request a free trial

Cellular Immunotherapy (Arbele/Avalon GloboCare) FAQs

  • Where is Cellular Immunotherapy (Arbele/Avalon GloboCare) headquartered?

    Cellular Immunotherapy (Arbele/Avalon GloboCare) is headquartered in Freehold, NJ.

  • What industry is Cellular Immunotherapy (Arbele/Avalon GloboCare) in?

    Cellular Immunotherapy (Arbele/Avalon GloboCare)’s primary industry is Drug Discovery.

  • Is Cellular Immunotherapy (Arbele/Avalon GloboCare) a private or public company?

    Cellular Immunotherapy (Arbele/Avalon GloboCare) is a Private company.

  • What is Cellular Immunotherapy (Arbele/Avalon GloboCare)’s current revenue?

    The current revenue for Cellular Immunotherapy (Arbele/Avalon GloboCare) is .

  • Who are Cellular Immunotherapy (Arbele/Avalon GloboCare)’s investors?

    Arbele and Change Agents have invested in Cellular Immunotherapy (Arbele/Avalon GloboCare).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process